Orestra (Estradiol)

Estradiol, the active ingredient in Orestra, is an estrogen hormone presented as a hormone replacement therapy for oral use. It treats menopausal symptoms and other estrogen‑deficiency conditions in women. GNH USA supplies Orestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Orestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Orestra is an estrogen medication that acts on hormonal pathways to alleviate symptoms associated with low estrogen levels. - Menopause: Improves vasomotor symptoms such as hot flashes and night sweats. - Hypoestrogenism due to ovarian failure: Restores normal estrogen levels and supports bone health. - Post‑menopausal osteoporosis: Helps maintain bone mineral density and reduces fracture risk.

Adverse reactions to estradiol vary with dose and route of administration.

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Breast tenderness: Sensitivity or swelling of breast tissue. - Headache: Transient tension‑type headaches. - Fluid retention: Mild peripheral edema. - Mood changes: Irritability or emotional lability.

Serious or Rare Side Effects: - Venous thromboembolism: Deep vein thrombosis or pulmonary embolism. - Stroke: Ischemic or hemorrhagic cerebrovascular events. - Hepatotoxicity: Elevated liver enzymes or cholestasis. - Endometrial hyperplasia: Abnormal thickening of the uterine lining. - Breast cancer: Potential increased risk with long‑term use.

When prescribing estradiol, clinicians should assess individual risk factors and monitor therapy closely. - Cardiovascular risk: Evaluate history of thromboembolic events before initiating therapy. - Cancer history: Review personal or family history of estrogen‑sensitive cancers. - Liver function: Check hepatic status as metabolism occurs primarily in the liver. - Bone health: Monitor bone mineral density in long‑term users. - Smoking status: Advise cessation, as smoking increases thrombotic risk. - Store at below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Estradiol may interact with several drug classes, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Combined oral contraceptives: Increased risk of thromboembolic events. - Anticoagulants (e.g., warfarin): May reduce anticoagulant effect, requiring dose adjustment. - Certain antiepileptics (e.g., carbamazepine): Accelerate estradiol metabolism, lowering efficacy.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): May increase risk of nausea and mood changes. - Thyroid hormone replacement: Estradiol can affect thyroid‑binding globulin levels, altering thyroid test results. - Statins: Potential for altered lipid‑profile response.